Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on May 30, 2025
Roman Ziemian Announces the Rise of AI-Powered Startups Fueling a Tech Renaissance Across the GCC
GlobeNewswire
·
May 30, 2025
DUBAI, United Arab Emirates, May 30, 2025 (GLOBE NEWSWIRE) -- Roman Ziemian today announced the emergence of a new wave of AI-driven startups transforming the Gulf region, marking a major milestone in the GCC’s technological evolution. With global …
Falcon Luxe Expands Private Jet Charter Offering with Block Hours Access
GlobeNewswire
·
May 30, 2025
DUBAI, United Arab Emirates, May 30, 2025 (GLOBE NEWSWIRE) -- Falcon Luxe, the private charter division of Falcon, part of Alex Group Investment, announces the availability of block hours private jet flight access. The concept is simple: clients pre- …
Paycheck-to-Paycheck to Financial Freedom: Bitcoin Solaris Opens Mobile Mining Access Ahead of Nova App Launch
GlobeNewswire
·
May 30, 2025
TALLINN, Estonia, May 30, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris (BTC-S), a decentralized blockchain protocol focused on real-world accessibility and mobile-first infrastructure, has officially opened early access to its Nova App—a passive mobile mining …
BioCryst Highlights Real-world Data Showing ORLADEYO® (berotralstat) Consistently Reduces HAE Attacks Across All Ages
GlobeNewswire
·
May 30, 2025
RESEARCH TRIANGLE PARK, N.C., May 30, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new data which highlights the reduction in the percentage of days with hereditary angioedema (HAE) symptoms among young children …
Arvinas to Present at Jefferies Global Healthcare Conference
GlobeNewswire
·
May 30, 2025
NEW HAVEN, Conn., May 30, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company working to develop a new class of drugs based on targeted protein degradation, today announced that management will participate in a …
Kornit Digital to Participate in the William Blair 45th Annual Growth Stock Conference
GlobeNewswire
·
May 30, 2025
ROSH-HA`AYIN, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. (“Kornit” or the “Company”) (Nasdaq: KRNT), a global leader in sustainable, on-demand, digital fashion and textile production technologies, today announced that Ronen Samuel, Kornit …
Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. as of and for the Three Months Ended March 31, 2025
GlobeNewswire
·
May 30, 2025
TEL-AVIV, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the “Company”), a renewable energy and power generator and developer of renewable energy and power projects in Europe, Israel and USA, today …
Zymeworks Announces NMPA Approval of Zanidatamab in China for Adults with Previously Treated, Unresectable or Metastatic HER2-high expression (IHC3+) Biliary Tract Cancer
GlobeNewswire
·
May 30, 2025
Zanidatamab is the first and only dual HER2-targeted bispecific antibody approved for HER2+ biliary tract cancer in China; conditional approval based on the results of the HERIZON-BTC-01 clinical study $20 million milestone payment to be received from …
Enterome presents positive Phase 1/2 MSS/pMMR metastatic colorectal cancer data in patients treated with EO4010 OncoMimics™ immunotherapy plus nivolumab at ASCO 2025
GlobeNewswire
·
May 30, 2025
Survival in 20 patients with MSS/pMMR mCRC at a median follow-up of 15.4 months was 40% at 12 months; median survival is currently 11.3 months Survival has currently reached plateau, with 34% (7/20) of patients still alive 80% of patients treated with …